Position in SHC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,648,296
-$7,674,210 QoQ
Shares Held
184,679
-87.8% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SHC Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Qube Research & Technologies Ltd holds $924,641,036 across 18 Diagnostics & Research names. SHC ranks #13 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | A |
Agilent Technologies, Inc.
|
2,280,319 | $259,910,759 | |
| 2 | DHR |
Danaher Corp /De/
|
1,348,956 | $255,762,057 | |
| 3 | DGX |
Quest Diagnostics Inc
|
734,714 | $143,989,249 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
188,774 | $92,788,084 | |
| 5 | NTRA |
Natera, Inc.
|
306,300 | $61,256,937 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
85,650 | $48,125,878 | |
| 7 | CSTL |
Castle Biosciences Inc
|
559,583 | $13,737,762 | |
| 8 | QGEN |
Qiagen N.V.
|
313,960 | $12,570,958 |
All Filings in SHC
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,648,296 | 184,679 | Shares | Sole | 2026-05-15 | |
| 2022-09-30 | $10,322,506 | 1,513,564 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $1,126,598 | 46,496 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,765,670 | 70,740 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $305,736 | 11,142 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||